Key result
Anticoagulation, HF therapy, and PCI reduce thrombus size ~67% and stabilize clinical status.
Why the study?
Accurate identification and management of cardiac thrombi in young patients with drug-induced dilated cardiomyopathy and thrombophilia are critical but not well characterized.
Case Report (n=1)
This case highlights the importance of evaluating for inherited thrombophilia in young patients with intracardiac thrombus and demonstrates the efficacy of combined anticoagulation and interventional therapies.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to atypical thrombi in young substance users; leaves open standardized diagnostic and management protocols.
Grigoroaea et al. (2025) conducted a case report in Coronary embolism and massive intraventricular thrombus (n=1). Anticoagulation, heart failure therapy, and percutaneous coronary intervention was evaluated on Thrombus size and clinical status. Management with anticoagulation, heart failure therapy, and percutaneous coronary intervention resulted in a two-thirds reduction in thrombus size and stable clinical status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: